News

Sustainability initiatives add to the complexity of managing reverse logistics for life sciences products

Only sites certified by NABP (in the US) and CIPA (Canada) will be allowed to purchase AdWords

The growth of healthcare business is attracting many new players to the pharmaceutical arena, challenging pharma’s relationships with patients

Drugmaker will collaborate with Web startup to develop personalized healthcare plans

USDA program started around when the FDA program did, and encountered similar problems

Patient Outcomes Research Moves Drug Development Beyond Clinical Results

Latest 10-year BLS projection sees moderate growth in US employment—except for ‘top executives’

While time- and temperature-sensitive biopharma shipping will grow dramatically in coming years, the capacity of air freight carriers is becoming constrained

Two industry communications agencies hope an online collaboration will lead to joint service offerings

European anticounterfeiting project tests end-to-end authentication

Launch includes a delayed-release formulation, in-house and contract sales force, a REMS program and a patient-adherence program

Kaiser Permanente files a citizen’s petition to revise FDA’s process of imposing REMS programs; also objects to restrictions on wholesale-distribution

CRM vendor invests in data sources to upgrade its offerings for life sciences regulatory and marketing operations

Sharps Compliance Corp. lauds California law to raise the profile of proper consumer disposal of used sharps

Participants will meet quarterly throughout the year to create supply chain use-scenarios with GS1 standards

Updated survey finds some improvements, but little overall progress since a 2006 survey

In the past year, FDA has imposed REMS programs for one out of four new drug approvals

Impersonators appear to be operating from the Dominican Republic

Early November recall of musty-smelling product is expanded from five to 54 lots; McNeil attributes the problem to packaging storage materials

With limited IT resources, the company is rolling out one business-intelligence application after another

Enterprise resource planning

FDA’s requirements for risk evaluation and mitigation challenge both new and existing commercialization processes

‘Print on demand’ changes traditional design, production and inventory practices for labels, inserts and other printed packaging

The signs are apparent that there is organized criminal activity focused on pharma logistics By Nicholas Basta

A review of 84 branded pharmaceutical products with changed ownership as of 2005 shows that many of them can continue to sell, often with much higher prices By Albert I. Wertheimer, PhD, MBA, Temple University, and Ellen F. Loh, BS, MBA, University of Maryland, Baltimore

Survey shows close interplay between manufacturers and their trading partners for supplemental services

UPS gets ready to receive GS1 product-tracking data from anyone

Fifteen of top 25 are drug or device makers; hospitals and distributors round out the list from the new Gartner subsidiary